Funding

New York Says $42 Million More Available for AIDS Drug Program

Published in Cancer Weekly, September 16th, 1996

About $42 million more has been made available for medication and services under the New York Drug Assistance Program for AIDS Patients (ADAP), state health officials report.

Three new drugs have been made available under the expansion announced: Nevirapine, a class of drugs that fight viruses that are mutated by other anti-viral medications; Cidofovir for treating the potentially blinding condition retinitis, and Liposomol duanorubicin for treatment of AIDS related cancers.

Another 121 drugs have been scheduled for restoration to the eligible list, including antibiotics for treating bacterial infections, psychotropics for treating HIV related...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1996-09-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry